The Two Scents of Limonene

Last updated on July 30, 2026 · Originally published July 28, 2020

The scent of oranges and lemons comes to mind when thinking about limonene, and although this is an apt descriptor, there is much more to learn about this molecule. The generation of limonene is often thought of as one of the simplest biosynthetic reactions in the terpene world, yet this well-studied molecule has found applications as an antimicrobial, biofuel, household cleaning agent, and more.

It’s also one of the clearest illustrations of a principle that runs through the whole terpene family: two molecules can contain exactly the same atoms, joined in exactly the same order, and still smell like completely different things.

One molecule, two mirror images

Limonene exists as two mirror-image forms called enantiomers, designated R and S. Enantiomers are molecules with identical atom connectivity but different, non-superimposable three-dimensional configurations. The useful detail to know is that one enantiomer is not superimposable on its mirror image.

There’s an easy experiment you can do to help understand this. Place your left hand palm down on a flat surface, then place your right hand on top and try to align every finger with its counterpart while keeping both palms facing down. You can’t. The same is true of the R and S enantiomers of organic molecules such as limonene.

Editor’s note: the description that follows is retained from the original article. Evidence published since then is discussed immediately below.

The oil extracted from the peel of the sweet orange Citrus sinensis (L.) Osbeck is mostly R-limonene, also called D-limonene, and it gives the fruit its distinct citrus scent. S-limonene smells more like pine.

An update: the two-scents rule is disputed

Since this article was first published, the neat textbook account above has come under sustained challenge — and the challenge is interesting enough to be worth setting out.

A 2021 analysis in the Journal of Chemical Education, pointedly subtitled “A String of Unchecked Literature Citings?”, traced the orange-versus-lemon attribution through decades of organic chemistry textbooks and concluded it should be corrected. A 2025 Perspective in ChemBioChem, titled simply “The Persistent Myth of Limonene’s Smell”, went further and argued the myth should be dismantled outright. The American Chemical Society has a video on the subject called, straightforwardly, The Limonene Myth.

The problem is not that enantiomers cannot smell different — carvone remains a textbook case where they clearly do. It is that limonene turns out to be a poor example. Published odour descriptions for purified limonene enantiomers are inconsistent, and the aroma of a citrus oil is not produced by limonene alone. Sweet-orange peel oil is commonly dominated by limonene, often at around 90%, whereas lemon oil generally contains a more complex mixture that also includes substantial β-pinene and γ-terpinene. Minor constituents with very low odour thresholds can shape a perceived scent out of all proportion to their concentration.

So the safer version is this: (R)-(+)-limonene dominates sweet orange peel oil, and (S)-(−)-limonene has often been described as piney or turpentine-like — but the clean rule that one enantiomer smells of oranges and the other of pine does not survive close examination. What holds is the underlying principle: handedness can matter to how a molecule is perceived, even when the atoms are identical.

The same question arises for other terpenes. Pinene also exists as enantiomers, and there the evidence points to differences in biological effect rather than in smell.

What your lab report does not tell you

Here’s the practical consequence: most routine gas chromatography does not separate enantiomers. Doing so requires a chiral stationary phase or another enantioselective method, which standard cannabis panels do not use. A certificate of analysis reporting a limonene percentage is reporting the total, not the ratio of R to S.

That means most routine cannabis COAs cannot show whether a sample contains predominantly one enantiomer or a mixture. The omission may matter for biological activity, authenticity and source identification — though as the section above suggests, an enantiomeric ratio alone would still not explain a product’s aroma, which emerges from the whole volatile mixture rather than any single compound.

Where limonene comes from

It might come as a surprise that the chemical precursor for both enantiomers of limonene is the same molecule: geranyl diphosphate, or GPP. This single compound is the precursor for most monoterpenes, and it is also involved in cannabinoid biosynthesis. Without too much squinting, you can see a limonene-like ring system in the terpenoid portion of cannabidiol. Both arise from the plant’s GPP chemistry, though limonene itself is not an intermediate in cannabinoid biosynthesis.

What determines which enantiomer a plant produces is the enzyme that performs the cyclisation. In 2025, researchers reported the first crystal structure of a (−)-limonene synthase from Cannabis sativa, revealing how the enzyme binds and cyclises its linear substrate. Work on the wider family has identified multiple terpene synthases in cannabis, concentrated in the glandular trichomes where the resin is made.

Commercially, limonene is obtained from citrus fruit by centrifugal separation or steam distillation — largely as a by-product of juice production, which makes it one of the cheapest terpenes available in bulk.

The chemistry, and why it degrades

Limonene is a cyclic monoterpene: a colourless liquid hydrocarbon built, like all monoterpenes, from two isoprene units.

Limonene is thermally stable enough to be distilled without decomposing, though at higher temperatures it will crack to form isoprene. Its principal weakness is oxidation. Exposure to oxygen, light and heat produces a changing mixture that can include carveol, carvone, epoxides and hydroperoxides.

That matters beyond aroma and analytical consistency: some oxidised limonene products are considerably more sensitising to skin than freshly purified limonene, which is why oxidation state is a real consideration in cosmetics. And for anyone storing cannabis or concentrates the implication is simple — the terpene profile on a certificate of analysis describes the product on the day it was tested, not the day you open it.

Beyond cannabis

Limonene is one of the most industrially useful terpenes there is. It works as a bio-based solvent and appears in a great many cleaning products, where it has displaced petroleum-derived alternatives. It is widely used in cosmetics, and in the food industry as a flavouring — valued partly for its ability to mask the bitterness of alkaloids. It also functions as a botanical insecticide.

You’ll find it concentrated in citrus peel oil — oranges, lemons, limes — and in juniper, dill, mint and a range of other plants. Along with myrcene, it is frequently among the more abundant monoterpenes measured in cannabis, though this varies considerably by cultivar.

What the research supports

Limonene has attracted more medical interest than most terpenes, and the evidence is genuinely promising in places — but it remains overwhelmingly preclinical, and that distinction matters.

Preliminary work suggests limonene may protect cardiovascular tissue after myocardial infarction by reducing damage from reactive oxygen species, and orange essential oil and its limonene component have shown antidepressant-like effects in mice. A 2023 study testing terpenes for anxiolytic effects in rats found a more complicated picture than the popular framing suggests, with results depending on dose and dosing schedule. We look at that literature in more detail in our piece on limonene, anxiety and depression.

Limonene is also used experimentally as a transdermal penetration enhancer, helping other compounds cross the skin — a property of interest for topical formulation rather than a therapeutic effect in itself.

Most of that evidence comes from animal and laboratory work. But limonene is also the subject of something rare in this field: a controlled human trial with a positive result.

In 2024, a Johns Hopkins team studied twenty healthy adults across nine double-blind sessions, with twelve completing an optional tenth, higher-dose session. Anxiety-related ratings declined as the D-limonene dose increased, and the combination of 30 mg THC with 15 mg D-limonene significantly reduced ratings of feeling “anxious/nervous” and “paranoid” compared with 30 mg THC alone. D-limonene did not systematically alter THC’s other measured subjective, cognitive or physiological effects, and produced no clear effects by itself. The authors concluded it could increase the therapeutic index of THC.

It is worth putting that next to the parallel result for pinene, where the same research group tested whether α-pinene could offset THC’s effect on memory and found that it did not. Ethan Russo, whose writing did much to popularise the modern entourage hypothesis, is a co-author on both papers. Taken together they suggest the entourage effect is neither folklore nor a general law, but something that has to be established one pairing at a time.

None of which makes limonene a treatment. The trial tested it as a modifier of THC’s effects, not as a stand-alone anxiolytic, and inhaled isolated compounds at controlled doses are not the same proposition as a citrus-forward chemovar. Controlled human evidence remains sparse, and a limonene-rich cannabis product is not a treatment for anxiety or depression. Our complete guide to cannabis terpenes sets out how much of the wider folklore holds up.

The vast potential for chemical diversity in terpenes has led to the identification of over 80,000 members of the terpene family, many of which, like limonene, have found uses in medicine and everyday life. Most people could name a terpene even if they’ve never heard the term — cholesterol, for instance, is a terpenoid.

So, the next time you’re talking terpenes and limonene gets brought up, there’s a question that you need to ask: which enantiomer?

Sources

1. Vieira AJ, et al. Limonene: aroma of innovation in health and disease. Chemico-Biological Interactions. 2018;283:97–106.
2. Zhang LL, et al. Antidepressant-like effect of Citrus sinensis (L.) Osbeck essential oil and its main component limonene on mice. Journal of Agricultural and Food Chemistry. 2019;67:13817–13828.
3. Durço AO, et al. D-limonene ameliorates myocardial infarction injury by reducing reactive oxygen species and cell apoptosis in a murine model. Journal of Natural Products. 2019;82:3010–3019.
4. Gutensohn M, et al. Cytosolic monoterpene biosynthesis is supported by plastid-generated geranyl diphosphate substrate in transgenic tomato fruits. Plant Journal. 2013;75:351–363.
5. Wiles D, Roest J, Vivian J, Beddoe T. Structural insights into monoterpene cyclisation of limonene synthase from Cannabis sativa. Biochemical and Biophysical Research Communications. 2025. doi:10.1016/j.bbrc.2025.152271
6. Booth JK, Page JE, Bohlmann J. Terpene synthases from Cannabis sativa. PLoS ONE. 2017;12(3):e0173911. doi:10.1371/journal.pone.0173911
7. Jenkins B, et al. Evaluating potential anxiolytic effects of minor cannabinoids and terpenes after acute and chronic oral administration in rats. Cannabis and Cannabinoid Research. 2023. doi:10.1089/can.2023.0083
8. Kvittingen L, et al. Limonene in citrus: a string of unchecked literature citings? Journal of Chemical Education. 2021. doi:10.1021/acs.jchemed.1c00363
9. Roth K. The persistent myth of limonene’s smell. ChemBioChem. 2025. doi:10.1002/cbic.202401085
10. Spindle TR, Zamarripa CA, Russo E, et al. Vaporized D-limonene selectively mitigates the acute anxiogenic effects of Δ⁹-tetrahydrocannabinol in healthy adults who intermittently use cannabis. Drug and Alcohol Dependence. 2024;257:111267. doi:10.1016/j.drugalcdep.2024.111267
11. Kumar L, Spindle TR, Zamarripa CA, et al. The individual and interactive effects of alpha-pinene and delta-9-tetrahydrocannabinol in healthy adults. Medical Cannabis and Cannabinoids. 2025;8(1):144–157. doi:10.1159/000547014

Originally published July 2020. Updated July 2026 to address the dispute over limonene’s enantiomer-specific odours, incorporate the 2024 human D-limonene trial and the 2025 α-pinene trial, add the 2025 structural work on cannabis limonene synthase, distinguish human evidence from animal and laboratory findings, and incorporate material from an earlier limonene profile.